CC BY 4.0 · Rev Bras Ginecol Obstet 2018; 40(11): 680-685
DOI: 10.1055/s-0038-1675807
Original Article
Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

Methotrexate Therapy for Ectopic Pregnancies: A Tertiary Center Experience

Ozgur Ozyuncu
1   Division of Perinatology, Department of Obstetrics and Gynecology, Faculty of Medicine at Hacettepe University, Ankara, Turkey
,
Atakan Tanacan
1   Division of Perinatology, Department of Obstetrics and Gynecology, Faculty of Medicine at Hacettepe University, Ankara, Turkey
,
Sinem Ayse Duru
1   Division of Perinatology, Department of Obstetrics and Gynecology, Faculty of Medicine at Hacettepe University, Ankara, Turkey
,
Mehmet Sinan Beksac
1   Division of Perinatology, Department of Obstetrics and Gynecology, Faculty of Medicine at Hacettepe University, Ankara, Turkey
› Author Affiliations
Further Information

Publication History

06 March 2018

20 September 2018

Publication Date:
28 November 2018 (online)

Abstract

Objective Our aim is to demonstrate the importance of methotrexate (MTX) therapy for the treatment of ectopic pregnancy (EP).

Methods This retrospective study consisted of 99 patients (72 tubal EPs, 20 pregnancies of unknown location (PUL), 4 cesarean section (CS) scar EPs and 3 cervical EPs) treated with MTX.

Results Methotrexate therapy was successful in 68.5% of EPs. There were statistically significant differences between the MTX success and failure groups based on ultrasonographic findings, patient complaints, gestational week and serum human chorionic gonadotropin (hCG) values. The MTX success rates in PUL and tubal pregnancies were 95% and 61.1%, respectively. The MTX success rates in single-dose, two-dose and multi-dose protocol groups were 86.9%, 28.6% and 40%, respectively. All cervical and CS scar ectopic pregnancies were treated successfully with MTX therapy.

Conclusion Methotrexate might be the first-line treatment option for EPs under certain conditions. Physicians must be more cautious in cases with higher hCG values, the presence of abdominal-pelvic pain, the presence of fetal cardiac activity, larger gestational sac (GS) diameters, and more advanced gestational weeks according to the last menstrual period.

Contributions

Ozgur Ozyuncu made substantial contributions to the conception and design of this study, data collection or analysis, and interpretation of data; he took part in writing of the article or critical review of the intellectual content, and he also took part in final approval of the version to be published. Atakan Tanacan made substantial contributions to the conception and design of the study, data collection or analysis, and interpretation of data; he took part in writing of the article or critical review of the intellectual content, and he also took part in final approval of the version to be published. Sinem Ayse Duru made contributions to data collection, analysis and writing of the manuscript. Mehmet Sinan Beksac made substantial contributions to conception and design, data collection or analysis, and interpretation of data; he took part in writing of the article or critical review of the intellectual content, and he also took part in final approval of the version to be published.


 
  • References

  • 1 Marion LL, Meeks GR. Ectopic pregnancy: History, incidence, epidemiology, and risk factors. Clin Obstet Gynecol 2012; 55 (02) 376-386 Doi: 10.1097/GRF.0b013e3182516d7b
  • 2 Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367 (9516): 1066-1074 Doi: 10.1016/S0140-6736(06)68397-9
  • 3 Helmy S, Koch M, Kölbl H, Grohmann-Izay B, Solomayer E, Bader Y. Correlation of the volume of ectopic pregnancy and MTX therapy outcome: a retrospective cohort study. Eur J Obstet Gynecol Reprod Biol 2015; 184: 108-111 Doi: 10.1016/j.ejogrb.2014.09.038
  • 4 Bouyer J, Coste J, Fernandez H, Pouly JL, Job-Spira N. Sites of ectopic pregnancy: a 10 year population-based study of 1800 cases. Hum Reprod 2002; 17 (12) 3224-3230 Doi: 10.1093/humrep/17.12.3224
  • 5 Alkatout I, Honemeyer U, Strauss A. , et al. Clinical diagnosis and treatment of ectopic pregnancy. Obstet Gynecol Surv 2013; 68 (08) 571-581 Doi: 10.1097/OGX.0b013e31829cdbeb
  • 6 Givens VM, Lipscomb GH. Diagnosis of ectopic pregnancy. Clin Obstet Gynecol 2012; 55 (02) 387-394 Doi: 10.1097/GRF.0b013e31824e3618
  • 7 American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 94: Medical management of ectopic pregnancy. Obstet Gynecol 2008; 111 (06) 1479-1485 Doi: 10.1097/AOG.0b013e31817d201e
  • 8 Rausch ME, Barnhart KT. Serum biomarkers for detecting ectopic pregnancy. Clin Obstet Gynecol 2012; 55 (02) 418-423 Doi: 10.1097/GRF.0b013e31825109f6
  • 9 Ailawadi M, Lorch SA, Barnhart KT. Cost-effectiveness of presumptively medically treating women at risk for ectopic pregnancy compared with first performing a dilatation and curettage. Fertil Steril 2005; 83 (02) 376-382 Doi: 10.1016/j.fertnstert.2004.06.068
  • 10 Fourie H, Bobdiwala S, Al-Memar M. , et al. OP11. 08: The management of recurrent ectopic pregnancy: a multicentre observational study. Ultrasound Obstet Gynecol 2017; 50: 82 Doi: 10.1002/uog.17796
  • 11 Jurkovic D, Wilkinson H. Diagnosis and management of ectopic pregnancy. BMJ 2011; 342: d3397 Doi: 10.1136/bmj.d3397
  • 12 Faden MS, Khayat S, Brown RN. Pregnancy of unknown location: a survey-based evaluation of when and why physicians intervene?. J Obstet Gynaecol Can 2017; 39 (05) 335-340 Doi: 10.1016/j.jogc.2017.01.007
  • 13 Özay AC, Emekçi Ö, Okyay RE, Bodur ART. Management of ectopic pregnancy: comparison of systemic methotrexate administration and surgical treatment; a retrospective study. Gynecol Obstet Reprod Med. 2016; 19: 86-90
  • 14 Practice Committee of American Society for Reproductive Medicine. Medical treatment of ectopic pregnancy. Fertil Steril 2008; 90 (5, Suppl) S206-S212 Doi: 10.1016/j.fertnstert.2008.08.049
  • 15 Moon HS, Hyun JH, Kim KS, Kim HJ, Moon SE, Koo JS. Use of Tuohy needle for intraamniotic methotrexate injection through the cervical canal in a cervical pregnancy after failure of systemic methotrexate treatment. Am J Obstet Gynecol 2010; 202 (05) e4-e6 Doi: 10.1016/j.ajog.2010.01.081
  • 16 Sowter MC, Farquhar CM. Ectopic pregnancy: an update. Curr Opin Obstet Gynecol 2004; 16 (04) 289-293 Doi: 10.1097/01.gco.0000136494.49334.6b
  • 17 Bachman EA, Barnhart K. Medical management of ectopic pregnancy: a comparison of regimens. Clin Obstet Gynecol 2012; 55 (02) 440-447 Doi: 10.1097/GRF.0b013e3182510a73
  • 18 Lipscomb GH. Medical therapy for ectopic pregnancy. Semin Reprod Med 2007; 25 (02) 93-98 Doi: 10.1055/s-2007-970048
  • 19 Alur-Gupta S, Cooney L, Senapati S, Barnhart K. Effectiveness of single versus two or multi-dose methotrexate protocol for the treatment of ectopic pregnancy: a meta-analysis. Fertil Steril 2017; 108: e379 Doi: 10.1016/j.fertnstert.2017.07.1102
  • 20 Lipscomb GH, Givens VM, Meyer NL, Bran D. Comparison of multidose and single-dose methotrexate protocols for the treatment of ectopic pregnancy. Am J Obstet Gynecol 2005; 192 (06) 1844-1847, discussion 1847–1848 Doi: 10.1016/j.ajog.2004.12.061
  • 21 Alleyassin A, Khademi A, Aghahosseini M, Safdarian L, Badenoosh B, Hamed EA. Comparison of success rates in the medical management of ectopic pregnancy with single-dose and multiple-dose administration of methotrexate: a prospective, randomized clinical trial. Fertil Steril 2006; 85 (06) 1661-1666 Doi: 10.1016/j.fertnstert.2005.11.055
  • 22 Barnhart K, Hummel AC, Sammel MD, Menon S, Jain J, Chakhtoura N. Use of “2-dose” regimen of methotrexate to treat ectopic pregnancy. Fertil Steril 2007; 87 (02) 250-256 Doi: 10.1016/j.fertnstert.2006.06.054
  • 23 Barnhart K, Coutifaris C, Esposito M. The pharmacology of methotrexate. Expert Opin Pharmacother 2001; 2 (03) 409-417 Doi: 10.1517/14656566.2.3.409
  • 24 Skubisz MM, Li J, Wallace EM, Tong S. Decline in βhCG levels between days 0 and 4 after a single dose of methotrexate for ectopic pregnancy predicts treatment success: a retrospective cohort study. BJOG 2011; 118 (13) 1665-1668 Doi: 10.1111/j.1471-0528.2011.03133.x
  • 25 Tawfiq A, Agameya AF, Claman P. Predictors of treatment failure for ectopic pregnancy treated with single-dose methotrexate. Fertil Steril 2000; 74 (05) 877-880 Doi: 10.1016/S0015-0282(00)01547-8
  • 26 Odejinmi F, Huff KO, Oliver R. Individualisation of intervention for tubal ectopic pregnancy: historical perspectives and the modern evidence based management of ectopic pregnancy. Eur J Obstet Gynecol Reprod Biol 2017; 210: 69-75 Doi: 10.1016/j.ejogrb.2016.10.037
  • 27 Brady PC, Missmer SA, Farland LV, Ginsburg ES. Clinical predictors of failing one dose of methotrexate for ectopic pregnancy after in vitro fertilization. J Assist Reprod Genet 2017; 34 (03) 349-356 Doi: 10.1007/s10815-016-0861-7
  • 28 Theodora M, Blanas K, Maritsa V, Assimakopoulos G, Sindos M, Daskalakis G. EP24. 22: Management of caesarean scar ectopic pregnancy with infusion of methotraxate into the gestational sac under ultrasound guidance. Ultrasound Obstet Gynecol 2017; 50: 373 Doi: 10.1002/uog.18717
  • 29 Prameela RC, Dev SV. Cervical ectopic pregnancy: 10 year experience at tertiary care hospital and current literature review. Int J Reprod Contracept Obstet Gynecol 2017; 5: 734-742 Doi: 10.18203/2320-1770.ijrcog20160575